Characterization of the decaheme c-type cytochrome OmcA in solution and on hematite surfaces by small angle x-ray scattering and neutron reflectometry.
The outer membrane protein OmcA is an 85 kDa decaheme c-type cytochrome located on the surface of the dissimilatory metal-reducing bacterium Shewanella oneidensis MR-1. It is assumed to mediate shuttling of electrons to extracellular acceptors that include solid metal oxides such as hematite (alpha-Fe(2)O(3)). No information is yet available concerning OmcA structure in physiologically relevant conditions such as aqueous environments. We purified OmcA and characterized its solution structure by small angle x-ray scattering (SAXS), and its interaction at the hematite-water interface by neutron reflectometry. SAXS showed that OmcA is a monomer that adopts a flat ellipsoidal shape with an overall dimension of 34 x 90 x 65 A(3). To our knowledge, we obtained the first direct evidence that OmcA undergoes a redox state-dependent conformational change in solution whereby reduction decreases the overall length of OmcA by approximately 7 A (the maximum dimension was 96 A for oxidized OmcA, and 89 A for NADH and dithionite-reduced OmcA). OmcA was also found to physically interact with electron shuttle molecules such as flavin mononucleotide, resulting in the formation of high-molecular-weight assemblies. Neutron reflectometry showed that OmcA forms a well-defined monomolecular layer on hematite surfaces, where it assumes an orientation that maximizes its contact area with the mineral surface. These novel insights into the molecular structure of OmcA in solution, and its interaction with insoluble hematite and small organic ligands, demonstrate the fundamental structural bases underlying OmcA's role in mediating redox processes.
Johs
A
A
Environmental Sciences Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA.
Shi
L
L
Droubay
T
T
Ankner
J F
JF
Liang
L
L
D000880:Anthraquinones / Q000378:metabolism / Q000494:pharmacology; D045304:Cytochromes c / Q000737:chemistry* / Q000378:metabolism*; D005290:Ferric Compounds / Q000378:metabolism* / Q000494:pharmacology; D005415:Flavins / Q000378:metabolism / Q000494:pharmacology; D006418:Heme; D008024:Ligands; D008958:Models, Molecular; D033363:Neutron Diffraction; D009571:Nitrilotriacetic Acid / Q000031:analogs & derivatives / Q000378:metabolism / Q000494:pharmacology; D010084:Oxidation-Reduction; D011487:Protein Conformation / Q000187:drug effects; D053838:Scattering, Small Angle; D020592:Shewanella / Q000201:enzymology; D012996:Solutions; D013329:Structure-Activity Relationship; D013499:Surface Properties; D014867:Water / Q000378:metabolism; D014961:X-Ray Diffraction
D000880:Anthraquinones; D005290:Ferric Compounds; D005415:Flavins; D008024:Ligands; D012996:Solutions; C408124:anthraquinone-2,6-disulfonate; D014867:Water; C000499:ferric oxide; D006418:Heme; D045304:Cytochromes c; D009571:Nitrilotriacetic Acid; C020326:ferric nitrilotriacetate